ATE323719T1 - Hla-a2 beschränktes tumorantigen-peptid, das von sart-1 abstammt - Google Patents

Hla-a2 beschränktes tumorantigen-peptid, das von sart-1 abstammt

Info

Publication number
ATE323719T1
ATE323719T1 AT99931554T AT99931554T ATE323719T1 AT E323719 T1 ATE323719 T1 AT E323719T1 AT 99931554 T AT99931554 T AT 99931554T AT 99931554 T AT99931554 T AT 99931554T AT E323719 T1 ATE323719 T1 AT E323719T1
Authority
AT
Austria
Prior art keywords
tumor antigen
antigen peptide
sart
hla
peptide derived
Prior art date
Application number
AT99931554T
Other languages
English (en)
Inventor
Kyogo Itoh
Terutada Kobayashi
Original Assignee
Greenpeptide Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greenpeptide Co Ltd filed Critical Greenpeptide Co Ltd
Application granted granted Critical
Publication of ATE323719T1 publication Critical patent/ATE323719T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT99931554T 1998-07-28 1999-07-27 Hla-a2 beschränktes tumorantigen-peptid, das von sart-1 abstammt ATE323719T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21294098 1998-07-28

Publications (1)

Publication Number Publication Date
ATE323719T1 true ATE323719T1 (de) 2006-05-15

Family

ID=16630822

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99931554T ATE323719T1 (de) 1998-07-28 1999-07-27 Hla-a2 beschränktes tumorantigen-peptid, das von sart-1 abstammt

Country Status (12)

Country Link
US (1) US6664232B1 (de)
EP (1) EP1103561B1 (de)
KR (1) KR20010071033A (de)
CN (1) CN1262562C (de)
AT (1) ATE323719T1 (de)
AU (1) AU765733B2 (de)
CA (1) CA2336486A1 (de)
DE (1) DE69930942D1 (de)
HK (1) HK1039946A1 (de)
ID (1) ID27162A (de)
NZ (1) NZ509585A (de)
WO (1) WO2000006595A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005029083A1 (en) * 2003-09-22 2005-03-31 Green Peptide Co., Ltd. Prognosis in cancer patients vaccinated with a cancer antigen peptide-associated agent
CN1910284B (zh) * 2004-01-20 2011-04-06 爱知县 由HLA-A2402-限制的Ep-CAM-特异的CTL识别的表位/肽及其应用
CA2940962C (en) * 2007-12-05 2018-07-24 International Institute Of Cancer Immunology, Inc. Cancer vaccine composition
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
NZ592461A (en) 2008-10-22 2012-12-21 Oncotherapy Science Inc Rab6kifl/kif20a epitope peptide and vaccines containing the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009715A1 (fr) 1990-11-21 1992-06-11 Leningradskaya Assotsiatsia 'poliplazma' Procede de pulverisation dans un jet de plasma de revetements biologiquement actifs sur un implant
US5554724A (en) 1994-03-24 1996-09-10 University Of Leiden Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof
CA2257531A1 (en) 1996-06-07 1997-12-11 Kyogo Itoh Tumor antigen proteins, genes thereof, and tumor antigen peptides
US6555652B1 (en) 1997-12-05 2003-04-29 Kyogo Itoh Tumor antigen peptide derivatives
US6838445B1 (en) 1998-07-10 2005-01-04 Kyogo Itoh Tumor antigen peptide originating in SART-1

Also Published As

Publication number Publication date
AU4801699A (en) 2000-02-21
CN1262562C (zh) 2006-07-05
CA2336486A1 (en) 2000-02-10
NZ509585A (en) 2003-05-30
CN1310723A (zh) 2001-08-29
KR20010071033A (ko) 2001-07-28
US6664232B1 (en) 2003-12-16
HK1039946A1 (zh) 2002-05-17
DE69930942D1 (de) 2006-05-24
WO2000006595A1 (fr) 2000-02-10
EP1103561A1 (de) 2001-05-30
ID27162A (id) 2001-03-08
AU765733B2 (en) 2003-09-25
EP1103561A4 (de) 2002-03-27
EP1103561B1 (de) 2006-04-19

Similar Documents

Publication Publication Date Title
CY1114164T1 (el) Μεθοδος ελεγχου της δραστικοτητας ανοσολογικα λειτουργικου μοριου
ATE375362T1 (de) Von cyclophilin b abstammende tumorantigen- peptide
CY1109699T1 (el) Νουκλεινικα οξεα που κωδικοποιουν πολυπεπτιδια πολυεπιτοπων
DK0668350T4 (da) Melanomassocieret antigen, epitoper deraf samt vacciner mod melanom
PL366575A1 (pl) Kompozycje oraz sposoby leczenia i diagnozowania raka jajnika
BR0013231A (pt) Complexos citocina-anticorpo múltiplos
DE68926303D1 (de) Peptide und antikörper, die die integrin-ligandbindung inhibieren
DE69935220D1 (de) Von menschlichem tumor stammendes polypeptidhormon phosphatonin
TR200003347T2 (tr) Neisseria meningitidis'denBASB029 polinükleotidleri ve polipeptidler
ATE323719T1 (de) Hla-a2 beschränktes tumorantigen-peptid, das von sart-1 abstammt
ATE412747T1 (de) Neues tumor-antigen-protein sart-3 und tumor- antigen-peptid davon
ATE464383T1 (de) Tumor antigen
WO2001029220A3 (en) Mage-a12 antigenic peptides and uses thereof
BR9911601A (pt) Polipeptìdios antigênicos de neisseria meningitidis, polinucleotìdeos correspondentes e anticorpos protetores
ITRM920506A1 (it) Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.
TR200000416T2 (tr) Neisseria loctoferrin bağlayıcı protein.
ATE354657T1 (de) Basb019 proteine und gene aus moraxella catarrhalis, antigene, antikörper, und verwendungen
CY1105820T1 (el) Basb027 πρωτεϊνες και γονιδια απο moraxella catarrhalis, αντιγονα, αντισωματα και χρησεις
ATE281524T1 (de) Moraxella catarrhalis pilq proteine
ATE356144T1 (de) Regulatorische/entfaltende peptide von ezrin
PT854727E (pt) Antigenios de rejeicao tumoral apresentados pelas moleculas b44-alh e suas utilizacoes
ATE293693T1 (de) Moraxella catarrhalis antigen basb117
IT8921396A0 (it) Procedimento per la sintesi di peptidi preventivamente identificati come siti di interazione di proteine interagenti.
DE60019613D1 (de) Moraxella catarrhalis antigen basb120

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties